Clinical Trial Update: Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD [Phase 2]

View source ↗

Summary

A Phase 2 COPD trial evaluating an inhaled corticosteroid-long-acting beta-agonist on endothelial function has been withdrawn. The sponsor was University of Mia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled glucocorticoid-long-acting beta-adrenergic agonist (ICS-LABA) combination (inhaled corticosteroid-long-acting beta-agonist combination)

Snippet

Sponsor: University of Miami | Conditions: COPD | Phase 2 | Status: WITHDRAWN